Abstract
SummaryThe bradycardia produced by benzquinamide or by P-2565 is not related to central parasympathetic stimulation. Studies on the isolated cat heart indicate that P-2565 does not have a direct effect on the isolated myocardium. Benzquinamide and P-2565 have ganglionic blocking properties as indicated by the tetramethylammonium test. In addition, the ability of benzquinamide and P-2565 to antagonize the guanethi-dine depletion of NE in heart tissue should be considered as a factor influencing the peripheral action of these agents on heart rate.The authors wish to acknowledge the capable technical assistance of Mr. Willie Treadwell and Mr. Daniel Walker. They also wish to thank Dr. S. Y. P'an of the Charles Pfizer Laboratories, Groton, Conn, for the generous supply of benzquinamide and P-2565.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
